2,469.00
+39(+1.60%)
Currency In JPY
Sector
Basic Materials
Industry
Chemicals - Specialty
Employees
1813
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Yoshiyuki Shimmyo | Managing Executive Officer, GM of Inorganic Chemicals Division & Director | 0 | 1964 |
| Tooru Sakamoto | Executive Off and Deputy Director of Inorganic Chemicals Business HQ, Procurement, Sales & Marketing | 0 | N/A |
| Watanabe Hiroyuki | Managing Executive Officer & Director of Healthcare Business Headquarters | 0 | N/A |
| Mr. Hiroshi Okubo | President, Chief Compliance Officer & Director | 0 | 1961 |
| Yoshio Nishiyama | Managing Executive Officer of General Affairs & HR Division and Director | 0 | 1962 |
| Mr. Kenichi Tanaka | Executive Chairman of the Board | 0 | 1954 |
| Akihiko Kikuchi | Director of Legal & IP Headquarters & Executive Officer | 0 | N/A |
| Mr. Yasunobu Kawazoe | Senior Managing Executive Officer, Head of Finance & Director | 0 | 1958 |
| Shigeru Mitani | Exec Director of Office of Environ, Safety and Quality Admin. & Manag. Executive Officer | 0 | N/A |
| Mikiya Horie | Senior Managing Executive Officer, Head of Bioscience Business Division & Director | 0 | 1960 |
Ishihara Sangyo Kaisha, Ltd. engages in the manufacture and sale of organic and inorganic chemicals in Japan, Asia, the United States, Europe, and internationally. The company offers titanium dioxide (TiO2) products under the TIPAQUE trade name, which includes white pigments for applications in paints, inks, plastics, paper, and other products; yellow pigments; and functional materials, such as ultrafine TiO2, ultrafine ZnO, electro-conductive materials, photocatalytic TiO2, high purity TiO2, titanium tetrachride, TiO2 for catalytic use, acicular type TiO2, glass coating, and battery materials. In addition, it offers matting agents; heat shield materials; agrochemicals, including herbicides, fungicides, insecticides, and nematicides; animal healthcare products; pharmaceutical reagents; and CF3-Pyridine organic intermediates for use in the pharmaceutical research. Ishihara Sangyo Kaisha, Ltd. was founded in 1920 and is headquartered in Osaka, Japan.